ASX Pharmaceuticals, Biotechnology & Life Sciences reporting and event calendar

What ASX-listed Pharmaceuticals, Biotechnology & Life Sciences companies are expected to lodge over the next three months.

13 dates listed. Generated 10 September 2026; the live calendar updates twice each weekday.

Thursday 22 October 1 event

  • PAB Patrys Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 15 Oct 2026 to 29 Oct 2026
    The last 9 quarterly cash flow report announcements from this company moved the share price -2.4% on the day, on average. Past movements are an observation, not a guide to what happens next.

Wednesday 28 October 1 event

  • VBS Vectus Biosystems Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 21 Oct 2026 to 4 Nov 2026
    The last 11 quarterly cash flow report announcements from this company moved the share price -1.8% on the day, on average. Past movements are an observation, not a guide to what happens next.

Friday 30 October 3 events

  • HXL Hexima Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 6 Oct 2026 to 23 Nov 2026
    The last 12 quarterly cash flow report announcements from this company moved the share price 0.0% on the day, on average. Past movements are an observation, not a guide to what happens next.
  • IVX Invion Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 23 Oct 2026 to 6 Nov 2026
    The last 7 quarterly cash flow report announcements from this company moved the share price -1.8% on the day, on average. Past movements are an observation, not a guide to what happens next.
  • TRP Tissue Repair Ltd Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 23 Oct 2026 to 6 Nov 2026
    The last 11 quarterly cash flow report announcements from this company moved the share price -1.5% on the day, on average. Past movements are an observation, not a guide to what happens next.

Saturday 31 October 1 event

  • TRP Tissue Repair Ltd Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 8 Oct 2026 to 23 Nov 2026
    The last 11 quarterly cash flow report announcements from this company moved the share price -1.5% on the day, on average. Past movements are an observation, not a guide to what happens next.

Monday 2 November 3 events

  • PAB Patrys Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 26 Oct 2026 to 9 Nov 2026
    The last 9 quarterly cash flow report announcements from this company moved the share price -2.4% on the day, on average. Past movements are an observation, not a guide to what happens next.
  • RGT Argent Biopharma Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 26 Oct 2026 to 9 Nov 2026
    The last 6 quarterly cash flow report announcements from this company moved the share price -2.5% on the day, on average. Past movements are an observation, not a guide to what happens next.
  • VBS Vectus Biosystems Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 26 Oct 2026 to 9 Nov 2026
    The last 11 quarterly cash flow report announcements from this company moved the share price -1.8% on the day, on average. Past movements are an observation, not a guide to what happens next.

Wednesday 4 November 1 event

  • ZLD Zelira Therapeutics Limited Estimated from past filings
    Quarterly Activities Report · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 28 Oct 2026 to 11 Nov 2026
    The last 5 quarterly activities report announcements from this company moved the share price -1.1% on the day, on average. Past movements are an observation, not a guide to what happens next.

Friday 6 November 1 event

  • CHM Chimeric Therapeutics Limited Estimated from past filings
    Quarterly Cash Flow Report (4C) · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 30 Oct 2026 to 13 Nov 2026
    The last 4 quarterly cash flow report announcements from this company moved the share price +2.8% on the day, on average. Past movements are an observation, not a guide to what happens next.

Sunday 15 November 1 event

  • TRP Tissue Repair Ltd Company-indicated window
    Clinical Trial Update · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 1 Oct 2026 to 31 Dec 2026
    From a company announcement on 30 Jan 2026
    The last 2 clinical trial update announcements from this company moved the share price +49.5% on the day, on average. Past movements are an observation, not a guide to what happens next.

Wednesday 9 December 1 event

  • IVX Invion Limited Estimated from past filings
    Clinical Trial Update · Pharmaceuticals, Biotechnology & Life Sciences
    Window: 29 Nov 2026 to 19 Dec 2026
    The last 3 clinical trial update announcements from this company moved the share price -0.9% on the day, on average. Past movements are an observation, not a guide to what happens next.

How each date is known

Company-stated date
The company named this exact date in an announcement.
Company-indicated window
The company indicated a period; the exact date is not confirmed.
Due by, under the Listing Rules
The latest date the ASX Listing Rules allow. Companies often lodge earlier.
Estimated from past filings
Inferred from this company's own filing pattern. Not a confirmed date, and not a prediction.

Browse by sector

GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).